222 related articles for article (PubMed ID: 29602831)
1. Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
Ho PY; Duan Z; Batra N; Jilek JL; Tu MJ; Qiu JX; Hu Z; Wun T; Lara PN; DeVere White RW; Chen HW; Yu AM
J Pharmacol Exp Ther; 2018 Jun; 365(3):494-506. PubMed ID: 29602831
[TBL] [Abstract][Full Text] [Related]
2.
Li PC; Tu MJ; Ho PY; Batra N; Tran MML; Qiu JX; Wun T; Lara PN; Hu X; Yu AX; Yu AM
Theranostics; 2021; 11(10):4858-4871. PubMed ID: 33754032
[No Abstract] [Full Text] [Related]
3. The Optimal Outcome of Suppressing Ewing Sarcoma Growth
Li DF; Yuan Y; Tu MJ; Hu X; Li YZ; Yi WR; Li PC; Zhao Y; Cheng Z; Yu AM; Jian C; Yu AX
Front Oncol; 2020; 10():222. PubMed ID: 32161722
[TBL] [Abstract][Full Text] [Related]
4. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
Petrek H; Batra N; Ho PY; Tu MJ; Yu AM
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6107-6117. PubMed ID: 31187211
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions.
Yi WR; Tu MJ; Yu AX; Lin J; Yu AM
Bioengineered; 2022 May; 13(5):12489-12503. PubMed ID: 35579419
[TBL] [Abstract][Full Text] [Related]
6. Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growth.
Petrek H; Yan Ho P; Batra N; Tu MJ; Zhang Q; Qiu JX; Yu AM
Biochem Pharmacol; 2021 Jul; 189():114392. PubMed ID: 33359565
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
8. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
10. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study.
Mitra R; Lin CC; Eischen CM; Bandyopadhyay S; Zhao Z
RNA; 2015 Jun; 21(6):1055-65. PubMed ID: 25852169
[TBL] [Abstract][Full Text] [Related]
11. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics.
Yi W; Tu MJ; Liu Z; Zhang C; Batra N; Yu AX; Yu AM
Acta Pharm Sin B; 2020 Jan; 10(1):159-170. PubMed ID: 31993313
[TBL] [Abstract][Full Text] [Related]
13. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents.
Traber GM; Yi C; Batra N; Tu MJ; Yu AM
RNA; 2024 May; 30(6):680-694. PubMed ID: 38429100
[TBL] [Abstract][Full Text] [Related]
14. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.
Zhang C; Wang H; Liu X; Hu Y; Ding L; Zhang X; Sun Q; Li Y
Oncogene; 2019 Mar; 38(11):1892-1904. PubMed ID: 30390072
[TBL] [Abstract][Full Text] [Related]
16. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
[TBL] [Abstract][Full Text] [Related]
17. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
19. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
20. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
